Abstract
Summary
Acromegaly is a rare endocrine disorder characterized by excessive production of growth hormone, which may lead to abnormal growth of the bones and soft tissues, including the face, hands, and feet. The management of acromegaly includes both medical and surgical options.
The global Management of Acromegaly market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Management of Acromegaly Industry Forecast” looks at past sales and reviews total world Management of Acromegaly sales in 2022, providing a comprehensive analysis by region and market sector of projected Management of Acromegaly sales for 2023 through 2029. With Management of Acromegaly sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Management of Acromegaly industry.
This Insight Report provides a comprehensive analysis of the global Management of Acromegaly landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Management of Acromegaly portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Management of Acromegaly market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Management of Acromegaly and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Management of Acromegaly.
United States market for Management of Acromegaly is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Management of Acromegaly is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Management of Acromegaly is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Management of Acromegaly players cover Pfizer Inc., Chiasma Inc, Novartis AG, Ipsen Biopharmaceuticals Inc, Wockhardt Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Management of Acromegaly market by product type, application, key players and key regions and countries.
Segmentation by Type:
Ectopic Acromegaly
Pseudo Acromegaly
Segmentation by Application:
Surgery
Drug Therapy
Radiation Therapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Ectopic Acromegaly
Pseudo Acromegaly
Segmentation by Application:
Surgery
Drug Therapy
Radiation Therapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer Inc.
Chiasma Inc
Novartis AG
Ipsen Biopharmaceuticals Inc
Wockhardt Ltd.
Troikaa Pharmaceuticals Limited
VHB Life Sciences Limited
GlaxoSmithKline plc
The global Management of Acromegaly market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Management of Acromegaly Industry Forecast” looks at past sales and reviews total world Management of Acromegaly sales in 2022, providing a comprehensive analysis by region and market sector of projected Management of Acromegaly sales for 2023 through 2029. With Management of Acromegaly sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Management of Acromegaly industry.
This Insight Report provides a comprehensive analysis of the global Management of Acromegaly landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Management of Acromegaly portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Management of Acromegaly market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Management of Acromegaly and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Management of Acromegaly.
United States market for Management of Acromegaly is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Management of Acromegaly is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Management of Acromegaly is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Management of Acromegaly players cover Pfizer Inc., Chiasma Inc, Novartis AG, Ipsen Biopharmaceuticals Inc, Wockhardt Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Management of Acromegaly market by product type, application, key players and key regions and countries.
Segmentation by Type:
Ectopic Acromegaly
Pseudo Acromegaly
Segmentation by Application:
Surgery
Drug Therapy
Radiation Therapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Ectopic Acromegaly
Pseudo Acromegaly
Segmentation by Application:
Surgery
Drug Therapy
Radiation Therapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer Inc.
Chiasma Inc
Novartis AG
Ipsen Biopharmaceuticals Inc
Wockhardt Ltd.
Troikaa Pharmaceuticals Limited
VHB Life Sciences Limited
GlaxoSmithKline plc
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Management of Acromegaly Market Size 2019-2030
2.1.2 Management of Acromegaly Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Management of Acromegaly by Country/Region, 2019, 2023 & 2030
2.2 Management of Acromegaly Segment by Type
2.2.1 Ectopic Acromegaly
2.2.2 Pseudo Acromegaly
2.3 Management of Acromegaly Market Size by Type
2.3.1 Management of Acromegaly Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Management of Acromegaly Market Size Market Share by Type (2019-2024)
2.4 Management of Acromegaly Segment by Application
2.4.1 Surgery
2.4.2 Drug Therapy
2.4.3 Radiation Therapy
2.5 Management of Acromegaly Market Size by Application
2.5.1 Management of Acromegaly Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Management of Acromegaly Market Size Market Share by Application (2019-2024)
3 Management of Acromegaly Market Size by Player
3.1 Management of Acromegaly Market Size Market Share by Player
3.1.1 Global Management of Acromegaly Revenue by Player (2019-2024)
3.1.2 Global Management of Acromegaly Revenue Market Share by Player (2019-2024)
3.2 Global Management of Acromegaly Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Management of Acromegaly by Region
4.1 Management of Acromegaly Market Size by Region (2019-2024)
4.2 Global Management of Acromegaly Annual Revenue by Country/Region (2019-2024)
4.3 Americas Management of Acromegaly Market Size Growth (2019-2024)
4.4 APAC Management of Acromegaly Market Size Growth (2019-2024)
4.5 Europe Management of Acromegaly Market Size Growth (2019-2024)
4.6 Middle East & Africa Management of Acromegaly Market Size Growth (2019-2024)
5 Americas
5.1 Americas Management of Acromegaly Market Size by Country (2019-2024)
5.2 Americas Management of Acromegaly Market Size by Type (2019-2024)
5.3 Americas Management of Acromegaly Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Management of Acromegaly Market Size by Region (2019-2024)
6.2 APAC Management of Acromegaly Market Size by Type (2019-2024)
6.3 APAC Management of Acromegaly Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Management of Acromegaly Market Size by Country (2019-2024)
7.2 Europe Management of Acromegaly Market Size by Type (2019-2024)
7.3 Europe Management of Acromegaly Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Management of Acromegaly by Region (2019-2024)
8.2 Middle East & Africa Management of Acromegaly Market Size by Type (2019-2024)
8.3 Middle East & Africa Management of Acromegaly Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Management of Acromegaly Market Forecast
10.1 Global Management of Acromegaly Forecast by Region (2025-2030)
10.1.1 Global Management of Acromegaly Forecast by Region (2025-2030)
10.1.2 Americas Management of Acromegaly Forecast
10.1.3 APAC Management of Acromegaly Forecast
10.1.4 Europe Management of Acromegaly Forecast
10.1.5 Middle East & Africa Management of Acromegaly Forecast
10.2 Americas Management of Acromegaly Forecast by Country (2025-2030)
10.2.1 United States Market Management of Acromegaly Forecast
10.2.2 Canada Market Management of Acromegaly Forecast
10.2.3 Mexico Market Management of Acromegaly Forecast
10.2.4 Brazil Market Management of Acromegaly Forecast
10.3 APAC Management of Acromegaly Forecast by Region (2025-2030)
10.3.1 China Management of Acromegaly Market Forecast
10.3.2 Japan Market Management of Acromegaly Forecast
10.3.3 Korea Market Management of Acromegaly Forecast
10.3.4 Southeast Asia Market Management of Acromegaly Forecast
10.3.5 India Market Management of Acromegaly Forecast
10.3.6 Australia Market Management of Acromegaly Forecast
10.4 Europe Management of Acromegaly Forecast by Country (2025-2030)
10.4.1 Germany Market Management of Acromegaly Forecast
10.4.2 France Market Management of Acromegaly Forecast
10.4.3 UK Market Management of Acromegaly Forecast
10.4.4 Italy Market Management of Acromegaly Forecast
10.4.5 Russia Market Management of Acromegaly Forecast
10.5 Middle East & Africa Management of Acromegaly Forecast by Region (2025-2030)
10.5.1 Egypt Market Management of Acromegaly Forecast
10.5.2 South Africa Market Management of Acromegaly Forecast
10.5.3 Israel Market Management of Acromegaly Forecast
10.5.4 Turkey Market Management of Acromegaly Forecast
10.6 Global Management of Acromegaly Forecast by Type (2025-2030)
10.7 Global Management of Acromegaly Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Management of Acromegaly Forecast
11 Key Players Analysis
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Management of Acromegaly Product Offered
11.1.3 Pfizer Inc. Management of Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Chiasma Inc
11.2.1 Chiasma Inc Company Information
11.2.2 Chiasma Inc Management of Acromegaly Product Offered
11.2.3 Chiasma Inc Management of Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Chiasma Inc Main Business Overview
11.2.5 Chiasma Inc Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Management of Acromegaly Product Offered
11.3.3 Novartis AG Management of Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Ipsen Biopharmaceuticals Inc
11.4.1 Ipsen Biopharmaceuticals Inc Company Information
11.4.2 Ipsen Biopharmaceuticals Inc Management of Acromegaly Product Offered
11.4.3 Ipsen Biopharmaceuticals Inc Management of Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Ipsen Biopharmaceuticals Inc Main Business Overview
11.4.5 Ipsen Biopharmaceuticals Inc Latest Developments
11.5 Wockhardt Ltd.
11.5.1 Wockhardt Ltd. Company Information
11.5.2 Wockhardt Ltd. Management of Acromegaly Product Offered
11.5.3 Wockhardt Ltd. Management of Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Wockhardt Ltd. Main Business Overview
11.5.5 Wockhardt Ltd. Latest Developments
11.6 Troikaa Pharmaceuticals Limited
11.6.1 Troikaa Pharmaceuticals Limited Company Information
11.6.2 Troikaa Pharmaceuticals Limited Management of Acromegaly Product Offered
11.6.3 Troikaa Pharmaceuticals Limited Management of Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Troikaa Pharmaceuticals Limited Main Business Overview
11.6.5 Troikaa Pharmaceuticals Limited Latest Developments
11.7 VHB Life Sciences Limited
11.7.1 VHB Life Sciences Limited Company Information
11.7.2 VHB Life Sciences Limited Management of Acromegaly Product Offered
11.7.3 VHB Life Sciences Limited Management of Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 VHB Life Sciences Limited Main Business Overview
11.7.5 VHB Life Sciences Limited Latest Developments
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Company Information
11.8.2 GlaxoSmithKline plc Management of Acromegaly Product Offered
11.8.3 GlaxoSmithKline plc Management of Acromegaly Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 GlaxoSmithKline plc Main Business Overview
11.8.5 GlaxoSmithKline plc Latest Developments
12 Research Findings and Conclusion